COVID-19, diarrhoeal disease and fragile health systems

Evidence suggests that COVID-19 will have only a small direct impact on our target group – under 5 children and their carers (adults of reproductive age) in low to middle-income countries. However, the indirect impacts, through disrupted health systems are likely to be very large indeed. Simon recently gave a presentation on this to the […]

Visionary Program – 7 questions

It was a pleasure to contribute to the Ashoka Visionary Program which is open to all and run by Ashoka out of Austria (Europe) and Athens (Eastern Africa and the Mediterranean Region). I kicked off the hour-long session with a short, top-level overview of the work ColaLife has done so far but then focussed on […]

Making the Case for Inclusion of Co-packaged ORS/Zinc on the WHO Model List of Essential Medicines for Children (EMLc)

The WHO Model List of Essential Medicines For four decades, the World Health Organisation (WHO) has devoted substantial effort to an essential medicines programme that seeks to improve access to the most needed drugs and devices. The meeting of the 21st WHO Expert Committee on the Selection and Use of Essential Medicines will be held […]